Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Liang Huang"'
Autor:
Lu Zhang, Yujun Dong, Hongling Peng, Hao Li, Mingzhi Zhang, Hui-Han Wang, Qinhua Liu, Liping Su, Liye Zhong, Wenjun Wu, Liang Huang, Xiaojing Yan, Lei Fan, Wenjiao Tang, Zhenling Li, Lintao Bi, Yan Li, Guangxun Gao, Li Gao, Ting-Bo Liu, Yongqiang Wei, Yao Liu, Yu Li, Hui Zhou, Chunyan Sun, Wenbin Qian, Dehui Zou, Huilai Zhang, Kaiyang Ding, Xiaobo Wang, Ou Bai, Wenrong Huang, Bing Chen, Lin Yang, Jia Song, Da Gao, Tong Chen, Jun Luo, Shuye Wang, Liangming Ma, Jian Li
Publikováno v:
Blood. 140:3609-3611
Autor:
Qiuxia Yu, Xiaoying Zhang, Na Wang, Liang Huang, Chunrui Li, Yicheng Zhang, Jianfeng Zhou, Gaoxiang Wang, Yang Cao
Publikováno v:
Blood. 140:10311-10312
Autor:
Jin Jin, Jiali Cheng, Na Wang, Liang Huang, Xiaoxi Zhou, Liting Chen, Hui Luo, Tianjiao Liu, Jiao Meng
Publikováno v:
Blood. 140:10265-10266
Publikováno v:
Blood. 140:9761-9762
Autor:
Zhenya Hong, Zhi Yang, Xiaoxi Zhou, Gaoxiang Wang, Mi Zhou, Yingzi Zhang, Peiling Zhang, Jinjin Huang, Li Meng, Haitao Ruan, Min Xiao, Yunyan Li, Linling Wang, Meiling Wang, Wei Zhu, Qianzhen Zhang, Junjie Shen, Jianfeng Zhou, Cheng Qian, Liang Huang
Publikováno v:
Blood. 140:4625-4626
Publikováno v:
Blood. 140:4604-4605
Publikováno v:
Blood. 140:9427-9428
Autor:
Chaojiang Gu, Shangkun Zhang, Tongcun Zhang, Yang Cao, Na Wang, Lifang Huang, Wenyue Cao, Hao Xu, Yi Xiao, Liang Huang, Chunrui Li, Dengju Li, Jia Wei, Yicheng Zhang, Min Xiao, Jianfeng Zhou
Publikováno v:
Blood. 136:516-519
Autor:
JIA Wei, Min Xiao, Zekai Mao, Yang Cao, Yi Xiao, Fankai Meng, Yicheng Zhang, Jianfeng Zhou, Liang Huang
Publikováno v:
Blood. 138:94-94
Disruption of TP53 gene occur in a subset of patients with refractory/relapse B-cell non-Hodgkin lymphoma (r/r B-NHL) and confer inferior prognosis. Recently, we reported the safety and efficacy of two clinical trials, administrating CAR T-cell infus
Publikováno v:
Blood. 138:3671-3671
Myelodysplastic syndrome (MDS) is a group of diseases with clonal proliferation of dysplastic bone marrow hematopoietic cells. Recent studies have established that the 'immune signature' is substantially different in low and high-risk MDS. Neverthele